US approves first pill for treatment of alopecia
The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe ...
Read moreThe Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe ...
Read moreThe anti-inflammatory drug leronlimab is now being pushed by a Filipino doctor as a possible treatment for seriously ill COVID-19 ...
Read moreThe pandemic has seen unprecedented global efforts to discover a safe and effective treatment, either by developing new medicines to ...
Read moreThe Department of Health said 540 more health workers were infected with COVID-19 during the past week, raising the total ...
Read moreSwiss pharmaceuticals giant Roche said Thursday the US authorities had given it emergency clearance for a test identifying patients most ...
Read moreWashington - The US Department of Homeland Security revealed to AFP on Tuesday new technical details regarding its highly anticipated study ...
Read moreWashington - An arthritis drug that was being closely watched for its potential use against COVID-19 has delivered disappointing results ...
Read moreThe longing to see her family is almost unbearable, but Carmencita Salonga Collins, a head nurse at the 112-year-old Philippine ...
Read moreZurich, Switzerland - Swiss pharmaceutical giant Roche said Friday it had developed an antibody test that it hopes to roll out ...
Read moreTokyo -It is approved for use in flu outbreaks and has been deployed to treat Ebola, but now Avigan is ...
Read moreIn tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.
6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines
Trunklines: 832-5554, 832-5556, 832-5558
© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.
© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.